17 Hrs
Source:
USA TODAY
USA TODAY
Ready to play
Ready to play
The FDA acknowledges ongoing shortages of estrogen patches used for menopause treatment, caused by increased demand following the removal of a black box warning and manufacturing limitations. While the agency is working with six manufacturers to boost supply, women continue to struggle with access, and some are turning to alternative therapies. Experts emphasize the importance of continued treatment and suggest trying different formulations or sources while the supply issues persist.
Notice: This Is an AI-Generated Summary
Comments (0)